We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
+9.8%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
-$15.8M
Cap. Flow
-$23.5M
Cap. Flow %
-13.36%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$14.5M
2
CTLT
CATALENT, INC.
CTLT
+$7.03M
3
AZTA icon
Azenta
AZTA
+$1.98M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZTA icon
1
Azenta
AZTA
$1.21B
$48.7M 27.61%
475,494
-22,131
-4% -$1.98M
CTLT
2
DELISTED
CATALENT, INC.
CTLT
$47.7M 27.05%
358,303
-56,334
-14% -$7.03M
CRL icon
3
Charles River Laboratories
CRL
$10.8B
$36.4M 20.66%
88,239
-34,974
-28% -$14.5M
BIO icon
4
Bio-Rad Laboratories Class A
BIO
$8.15B
$31.8M 18.06%
42,679
– –
CELL
5
DELISTED
PhenomeX Inc. Common Stock
CELL
$11.7M 6.62%
596,802
– –

Similar funds

RCGV
Ribbit Capital GP V Palo Alto, California $19.8M AUM
SCM
Stamina Capital Management New York $13.3M AUM 71.17% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
OHU
Odey Holdings (UK) London, United Kingdom $12.4M AUM 20.7% 1-Year Est. Return
OA
Oakhurst Advisors Los Angeles, California $21.3M AUM 8.8% 1-Year Est. Return
JM
Jeneq Management New York $22.3M AUM 47.87% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Tower House Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Tower House Partners held 5 positions worth $176M, down 8.2% from $192M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tower House Partners withdrew a net $23.5M in Q3 2021, reducing 3 holdings. Its largest reduction was Charles River Laboratories, cutting an estimated $14.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tower House Partners's biggest Q3 2021 reduction was Charles River Laboratories, cutting an estimated $14.5M.
  • Tower House Partners's ten largest holdings make up 100% of its $176M portfolio in Q3 2021.
  • Tower House Partners opened 0 new positions and closed 0 in Q3 2021.
  • Tower House Partners's portfolio value fell 8.2% quarter-over-quarter to $176M.

Based on Tower House Partners's 13F filing for Q3 2021, filed 15 Nov 2021.